Monday, November 30, 2009
Sunday, November 22, 2009
WASHINGTON – A bruising debate on health care awaits the Senate after Thanksgiving now that the historic legislation has cleared a key hurdle over the opposition of Republicans eager to inflict a punishing defeat on President Barack Obama.
The bill would extend coverage to roughly 31 million who lack it, crack down on insurance company practices that deny or dilute benefits and curtail the growth of spending on medical care nationally.
In the final minutes of a daylong session, Majority Leader Harry Reid, D-Nev., accused Republicans of trying to stifle a historic debate the nation needed.
The Republican leader, Sen. Mitch McConnell of Kentucky, said the vote was anything but procedural — casting it as a referendum on the bill itself, which he said would raise taxes, cut Medicare and create a “massive and unsustainable debt.”Click to read.
Thursday, November 19, 2009
Dr George and Delores Jones, a correspondent for AOL speak about dealing with depression and change through inspiration and spirituality.
Thursday, November 12, 2009
The health care reform bill (HR 3962) that just passed the House of Representatives is bad on so many levels it is difficult explain. As it stands, it will destroy both the doctor patient relationship and change the practice of medicine as we know it.
We have one of the finest health care systems in the world. It has been built on a foundation of choice. Doctors were free to choose the care that they deemed necessary to treat their patients, and patients were free to seek the medical care of their choice. Initially, the foundation was shaken by the rise of the managed care system with capitation. However, over the past 10 years, capitated plans which limit access to specialists have given way to the rise in power of insurance companies. They have used their anti-trust exemption to craft a system that has used monopoly to increase profits on the backs of both doctors and patients.
BusinessWeek has broken the story that large employers like Goldman Sachs and Citigroup are among the first on the list to receive the H1N1 vaccine.Clusterstock, the business blog, has added the nuance that not only has Goldman Sachs received the same number of vaccinations as Lennox Hill hospital in New York City -- the finance giant got its hands on the doses beforemany hospitals.
Goldman Sachs' PR reps want to make it clear to the public that the CDC distributes vaccines to many types of large employers, such as Time Warner and New York University. The idea is to get the vaccine to people at many points of potential infection, giving the H1N1 vaccine to those who come into contact regularly with high risk groups within large companies. Goldman Sachs has received 200 H1N1 vaccines, Citigroup 1,200.
This "guest list" treatment makes sense for some early recipients of the H1N1 vaccine. Hospital workers at Memorial Sloan-Kettering and the New York Presbyterian Healthcare System clearly need early protection -- and got some of the first doses along with Goldman.
Friday, November 6, 2009
This show is an interview between Dr. Elaina George and Dr Emelita Breyer. Dr. Breyer is from the Breyer Foundation, an independent organization dedicated to finding solutions to health care reform that does not add to the deficit, or raise money on the backs of the people through taxation.
She has a thorough understanding of the sanctity of the doctor patient relationship. And has real solutions that will protect the things that make the US healthcare system the best in the world.
Tuesday, November 3, 2009
Got Sugar in the Blood? Change Your Lifestyle Today!
Do you remember your elders speaking about “sugar in the blood”? Do you have a friend or family member who suffers from diabetes? The importance of understanding high blood sugar is critical to the management of our often fast-paced, unhealthy, and stressful lives. A few years ago I had the opportunity to visit the “Bodies – The Exhibition” and experienced the most engaging presentation on the anatomy and pathology of the human body. Cadavers, adult and fetus, were on display to showcase the miracle of the body and the importance of good health and exercise. This poignant visit, which highlighted all of our major bodily systems, provides the inspiration to urgently share information regarding sugar – the crack cocaine of the Black of the community!
Sunday, November 1, 2009
There has been a lot of confusion about what ingredients are in the H1N1 Vaccine. In order to distill the information to make it easier for you to make an informed choice, here is a brief synopsis of the information provided by the manufacturers in their package inserts.
There are 4 manufactures who have been approved to sell H1N1 vaccine in the US. They are: Novartis, CSL, Sanofi/Pasteur and MedImmune
1. Novartis makes an injectable vaccine for ages 4 and above
Ingredients: Thimerosal (Mercury) both in the single dose and the multi dose vials
Antibiotics - polymyxin and neomycin (can be neurotoxic)
Manufactured with phenol (the chemical used on skin in cosmetic face peals to remove wrinkles)
Note: They recommend that children ages 4-9 get 2 injections one month apart. This would increase the risk from a reaction to the mercury (e.g, neurological damage such as Gullain-Barre or possibly Autism)